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Tmnor necrosis factor-a is considered to be one of the 
important mediators in the pathogenesis of psoriasis. A 
strong association of juvenile onset psoriasis with the 
major histocompatibility complex encoded HLA-Cw6 
antigen has been reported but it is unclear whether 
Cw6 itself or a closely linked gene is involved in the 
pathogenesis. Tlus study has focused on the association of 
promoter polymorphisms of the major histocompatibility 
cotnplex encoded tmnor necrosis factor-a gene with 
psoriasis and psoriatic arthritis. Tun10r necrosis factor-
a prot:noter polymorphisms were sought by sequence-
specific oligonucleotide hybridization and by direct 
sequencing in Caucasian patients with juvenile onset 
psoriasis and with psoriatic arthritis and in healthy con-
trols. A mutation at position -238 of the tmnor necrosis 
R ecent studi e~ have found a strong genetic background for psoriasis and psoriatic arthriti s, whi ch is emphas ized by a high concordance r;lte among m onozygotic tw ins of 55-70% (Elder el a/, "J 994a). Alth ough genome-wide sea rches fo r linked genes in affected Gmili es 
have come up with several chromosome regio ns co-segregating with 
the disease, the strongest association has been established for genes of 
th e maj or histoco mpatibili ty compl ex (M 1-JC) . For psoriasis the highest 
relative risk (R.R) h:1s been found for H LA-Cw6, particularly in 
pati ents with early onset· of th e disease (< 40 yea rs) and a positi ve 
Gm il y history (Eld er ct a/, 1994b). Pati ents with pso riati c arthritis (PsA) 
have a higher fi·cqu ency of HLA -B27 an.d the association of PsA with 
HLA- w6 is weaker (G ladman ct a/, 1987) . l'he l-ILA associati on of 
psoriasis has be~n shown to include the B locus (B 17, .B37 , B57) and 
to extend to th e class ll genes H LA-D LU31 *0701, - DQA 1-*0201, 
and -DQ131 *0303 (Schmitt-Egenolf et a/, 1993) . Almost all psoriasis-
associated l-ILA antige ns are in lin kage disequilibrium and one possible 
explanatio n co uld be that in additi o n to HLA class I and class II genes 
o ther genes encoded within th e M HC are in volved in th e disease 
path ogenesis. O ne ~u ch ca ndidate is tum or m:crosis f.1c tor- a (TNF-
a). T he gene fo r TN F-a is located within th e class Ill region of the 
Manuscrip t n:cc iv<.:d March 2 1. 1997 ; n:vis<.:d June 5, 1997; accepted for 
pub li ca tio n June 24, 'I 997. 
R eprint req uests to: Dr. T. H o hl er, I. M eclizinische I<linik unci Po liklinik, 
j o hannes G utenberg-U niversittit M ainz, Langcnbeckstr. 1, 55 101 Mainz, 
Gennan y 
Abb reviatio ns: M H C , major histocompatibi li ty complex; PsA, psoriati c 
arth ritis; ru\., re lati ve risk; TNF-a , tumor necrocis f:H.:to r- a.. 
factor-0'. promoter was present in 23 of 60 patients (38'Yo; 
p < 0.0001; P corr < 0.008) with juvenile onset psoriasis and 
in 20 of 62 patients (32%; p < 0.0003; Pcorr < 0.03) 
with psoriatic arthritis, compared with seven of 99 (7%) 
Caucasian controls. There was a t:narked increase of 
homozygotes for this nllltation in the psoriasis group. 
Another n1.utation at position -308 was found in similar 
proportions of patients and controls. Our study shows a 
strong association of the tmnor necrosis factor-a pro-
moter polymorphism at position -238 with psoriasis and 
psoriatic arthritis . Our findings suggest that this promoter 
polymorphism itself or a gene in linkage disequilibrium 
with tumor necrosis factor-a predispose to the develop-
ment of psoriasis. Key IVords: cytokines/HLA antigens/ 
linlwge disequilibrium/major histocompatibility complex. 
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MH C between I-ILA-.B and HLA-DI< .. (Ca mpbell and T rowsda le, 
1993). 
Sever:1l reports have impli cn ed TN F-a as an impo rtant cytokin e in 
th e pathogenesis of pso riasis. TN F-a co ncentratio ns have been shown 
to bt: in creased in early psori atic lesio ns (Ettehadi et a/, 1994) . M onocytes 
o f psoria tic pati ents prod uce higher kvels of TN F-a than controls 
(.Bo nif.1ti et a/, "1994). TN F-a and intt: rfe ro n-y (IFN -y) have been 
shown to stimub te the release of imerleukin -8 (IL-8) by keratin ocytt:s 
and fibroblasts (Larsen et a/, 1989; Ba rker e1 a/, 1990; Nickoloff et a/, 
199 1 ). lL-8 is a signal for T-ct:ll and neutrop hil mjgration into the 
epidermi s. In additio n TNF-a and IFN-y can induce the producti on 
of transformin g gro wth fi1 cto r-a (TGF-Ct.) by ke ratinocytes w hi ch is 
believed to dri ve hyperproliferatio n o f th ese ce lls (N ickoloff" ct a/, I ':>9 .1; 
Barker et a/, 1991). 
TN F-a exprt:ss ion is co ntro lled at th e transcri ptio nal and pos t-
tra nscriptio nal level. Two G versus A transiti ons in th e promo ter region 
at positi ons -308 (Wilso n et a/, 1993) and -238 (D ' Alfo nso and 
Richiardi, 1994) have been shown to inAu ence TNF-Ct. express io n. 
At position -308 allele 308.2 (A :~ t -308) is :~ssoc i a ted w ith higher 
constitutive and indu cibl t: levels of TN F-a (Wi lson e1 a/, "1994), 
w her<::as fo r the TNF-238.2 (A :~t -238) allele functio nal const:llu enct:s 
are not ye t clear (Pocio t el (1 /, 1995). 
In this in ves tiga tion we show that the TN F-238.2 pro moter poly-
morphism is associated with a higher R.R ro develop pso riasis than 
l-ILA class I antigens. T his pro mo ter va riant is part of the juvenile 
o nset psoriasis-associated haplotype Cw6-.B57-T N F-238 .2-DR 7. 
MATEI~ I ALS AND M ETHODS 
Patients Sixty C aucasian patients wir h pso riasis vu lga ris Ii.dfi lling the criteria 
of j uve nile o nse t pso rias is (o nse t not later than at the age of 40 yea rs and a 
positi ve fa mily histo ry) and 62 C aucasian patients ' ith PsA were recruited fro m 
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the Depa rtment of Dermato logy, Uni v<.!rs ity C lini c of Mainz. for this stud y. 
The psorios is group incl uded 2·1 female (35%) and 39 nwk (65%) subj<x ts. The 
median age of the paticms was 43.7 y (range 22-79 y). PsA was detlned as 
in A::111111 1 ~1 tO ry arthr.itis, sero negative for rh e u111aroid Etctor :1 11 d assoc i ::~tcd w ith 
pso ri asis (Gladman, 1994). All PsA patients were seen by a rh eu n1atologist 
(E.IVI.- H. or I'.H. ) and joint .involvemenr confmned by radiologic or sc imi-
graphi c investigatio ns. These p:ltic:.· n rs were ncg:1 ri ve fo r rheun wroid fa c to r and 
all but two also had j uvenile onset psoriasis. All patients had pso ri asis vulga ris. 
Twenty-three were· fcrm le (37. I%) and 39 (62.9'){,) were· male; the medi:m age 
ol· the patients was 52.7 y (range 34--82 y) with a medium disease duration of 
I 11.7 y (range 2- 39 y) . Twenty-nin e pati<.! ms had peri phera l arth ritis and 34 
spondyloarthropath y ( I 8 with periphera l in volvement). T he nomul contro l 
pop ulation consisted of 9'.1 umelated. hea lth y, white Ca ucasoid persons llco m 
romine consecuti ve patemi ty cases studied at th e lmtitute of Leg<~ l Medicine. 
P:1ticnrs Cl m e fro111 t:hc Mainz ::1rea. Th en~ were 47 ft:rn::lle ::J JJcl 52 m:1le 
individuals. Hea lth status w;JS cletenn inccl by a questionaire. 
Data co n ccmin~ HLA cb ss I and class II a ssoci:~ti o ns of these stud y populations 
have been publ ished pre·viously (Hohler cr a/. 1 '!%). 
TNF-a promoter polymorphisms A 328-bp ti·agment spanning position 
-3'.16 to - 6'.1 oi" the 5' umramlated region of the TN I' -a gene was ampli fted 
using primers TNF-39(, (5' -TTCCTGCATCCTGTCTGGAA-3') and TNF-
.(,9 (5'- AGCGGAAAACTTCCTTGGT-3'). A p:mcl of previously l-ILA-
DR.-typed sa n1 ples was ini tia ll y typed for the polymorphisms by sequencing 
the entire 32H-bp fl·<~gn1 cnt . T his led to the identification of· :1 nutnber of 
heterozygous and homozyous indi vidua ls fo r each of the fo m polymorph isms. 
TNF-protnoter all eles in the srud y subjects were detected by dot blot ana lysis 
of ampli fied DNA incorporating in e·ve ry :1 nalysis a panel of sequenced refe rence 
sampl es. Four digoxigenin- labeled oligo nucleotide probes were used for the 
idcntiti ca tion of the promoter alleks (D'A ifomo and J(ichiardi, 1994). Fi lrcrs 
were hybridized at 40°C and w:~s h ed wi th tetr:~m e th ylannnonium chloride 
at the remperatures prev iously described (D 'Aifonso and l"l...ichiardi, 1994). 
H ybridi z:nio n and co lo r detection with an ti d igoxige nin ~Htti body coupled 
alka line phosphatase were• c:1 rried out according to the manu f.1crurc r's instruc-
tions (l3oehringer, l\llannheim, Ger111:1ny). 
Statistical analysis The freque ncies of TN F-a promoter :~llel cs were com-
p;u ed between pati ents 'v ith j uven ile o nset pso ri asis. PsA. :1 nd contro ls by chi 
square rem with Yates correction to r small nutn bcrs. When multiple compariso ns 
;'Ire mJd e signifi c mr :~.ssoci :~tions may ar ise by ch:J nce. T o :Jvoid such e rro rs p 
va lu es '~' L' tT co rrected w ith the nuh1ber of allel es tested in the e n tire ~lssoc i ;Hi on 
study ( It\ fo r HLA-A, 38 fo r HLA- L3 , 10 fo r l-ILA-C, 13 for D l<J3 1, and fo ur 
fo r TNF-a; 83 all eles tested). J"I.J"l..,; associated with a parricubr allele were 
ca lculated using a chi -square distribution: 1'-.R. = (nl X n4) / (n2 X n3) . where 
nl is thL· nun 1bcr of patients with all ele x, n2 is the nurnber of controls with 
allele x, and n3 and n4 are the correspondi ng proportions of individuals in 
patient. and co ntrol groups not. ca rrying all ele x (Dyer <1nd W:nrens, I '.194). In 
each group the distribu tion of TN F-a promoter genotypes was checked for 
deviations ri·om J-larcl y-Wcin bcrg cqui li briu111 usin g an exact test (G uo :m d 
T hompson. 1\192). Lin kage disequilibrium between l-ILA- C, I-ILA-H. DI<J3"1"', 
and TN F-a was tested by chi -square test and by an exact test (Zaykin cr 11/, 
I '.195) . T he p va lues wne corrected fo r the number of <J II eles tested (38 for 
1-I LA-il, IU fo r l-ILA-C, 13 for Dl<-.13. and four for TNF-a; 65 all eles tested); 
p va lues < 0.05 were rega rded as signiri cant. 
R .ESULTS 
TNF-238.2 is increased in psoriasis and in PsA We fo und a 
s.ignifi ca nt increase of subj ects ca rrying A <1t position -238 in the 
psoriasis (38% r;s 7%.; p < 0.0001) and th e PsA group (32% f!S 7%; 
p < 0.0003) (Table 1). Gene ti-eq uencies for th e TNF-238.2 alle le in 
contro ls we re similar to those reported in the li te rature for west 
E uro pea n c;lUcas ians (D 'Aifonso and Ri chiardi , J 994; Pociot er a/, 
1995) . TN F-promoter alle le fi:equenc ies were simi lar am o ng m ale and 
fe male patients. 
The o bserved difle rences were further underlined by th e prese nce 
of five TNF-238.2 ho m ozygous perso ns in the psoriasis gro up . 1-lomo-
zygos.ity fo r TNF-238.2 is expected in o nly 1.2 of I 000 investigated 
subjec ts accord ing to the gene fi·equ ency ofTNF-238.2 (3.5'X•) in the 
control population. We did nor observe any ho m ozygous subj ec t in 
the PsA gro up w hi ch is pro bably du e to chance as we would have 
expected l. 6 ho m ozygous subj ec ts in this gro up accord ing to the 
H ardy-We in berg eq ua tio n . T here were no ditference> in th e fi·equency . 
o f the TNF-308.2 po lym o rphism and va ri at io n at thi s locus was 
independe nt of th e TNF-238.2 polymorph ism . In PsA patie nts there 
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Table I. TNF-a. promoter genotype frequencies in the 
investigated groups 
Locus/ genotype Contro ls l'soriasis PsA 
(n = 99)'" (n = 60) (n = 62) 
11 1)4, 11 %, 11 % 
TN F-a -238 
GIG 92 <)3 37 11 62 42" 68 
G/ A 7 7 18 30 20 32 
A/A 0 () 5 8 () 0 
TN F-a -308 
GI G 73 74 52 87 47 76 
C I A 20 20 7 11 II 18 
A/ A 6 6 2 4 6 
1
'p < 0.000 I. Pcorr < n.OOS: G/ A !llld A/ A l't.TSIIS G I G in psori:Hi c pari~nts compared 
wirh comrols. 
"p < 0.0003. Pnm < 0.03: Gl A :wei A/ A IICf.'IIS GIG in Sllbj~.tts wir h PsA t:Olllp:lrcd 
wirh contro ls. 
' n, lllllllbcr or invcstig:ltCd p<tticnt:'. 
Table II. Linkage disequilibrium b etween HLA-DR, HLA-B, 
and HLA-Cw alleles and the TNF-238 .2 alelle 
Pso ri asis 
Cw6 + 
D57 + 
DIU + 
PsA 
Cw6 + 
1357 + 
DIU + 
TNF-238. 2 
+ 
21 13 
2 22 
20 I 
3 34 
15 13 
8 
II 10 
9 3 1 
9 2 
II 3'.1 
5 8 
15 33 
''NS, nor signific:nH. 
N 
58 p < 0.0003; Pcorr < 0.02 
58 p < 0.0000 I; Pcorr < 0.0006 
58 p < 0.06: p,.0 ,... = NS" 
22 
61 p < 0.04; P ccm = NS 
(,j P < 0.0009; Pcorr = NS 
61 p = NS 
was no associatio n between any promote r po.lymorphism and the 
patte rn of j oim in volvem ent. 
Linkage disequilibrium between TNF- 238 .2 and HLA-
B57 T he previo usly published data o n HLA class I and cl<lSS 11 
antigens in o ur population (Ho hler et nl, 1996) were used to test TNF-c:x 
polym o rp hism s at positions -238 and -308 for linkage disequiLibrium to 
H LA-B, 1-lLA-C, and HLA-DRB I (Table II). In the psoriasi s group 
there was vet·y srrong]jnkage disequi li brium to HLA-857 (p < 0.00001; 
Pcorr < 0.0006) and a weaker one to Cw6 (p < 0.0003; Pcorr = 0.02) 
and to DRJ3 1 *070 '1 rPcorr = not sign ifican t (NS).J . T hi s is re Aected by 
the f.1ct that o nly eight of 23 (34. 8%) observed TNF-238.2 alleles in 
this group occurred independently from HLA-B57 (five patie nts were 
ho n10zygous for TNF-238.2 and ca rried anothe r B all ele in add ition 
ro B57) compared w ith ·11 of 20 aLl eles (55%) in the PsA gro up. 
In the PsA patients there was a weaker linkage d iseg uiLi brium to 
B57 (p < 0.0009; Pcorr = NS) and even less to H.LA- Cw6 (Peon· = NS) 
and to DIU31*0701 (P.:orr = NS) . In additio n , we observed a ve ry 
stro ng co nserva tio n of th e Cw6-B57-TNF-238.2 hap lotype in psori asis 
subj ects w hich accounted for 15 of 23 (65.2'){,) TNF-238.2 ca rrying 
haplotypes compared with eight of 20 (40%) in th e PsA group. 
Highest RR conferred by TNF- 238 .2 T he h_ighest R.R to develop 
psoriasis was associated with ho m ozygosity fo r TNF-238.2 in th e 
psoriasis gro up and w ith hete rozygosity for this allele in the Ps.A. group 
(Table III) . Difl:eren ces between psoriasis and PsA in the im portance 
o f the TNF-238 .2 polym orphism are parti ally expla in ed by differen ces 
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T able III. RRs conferred by the TNF- 238 .2 allele compared 
with Cw6, B57, and DRB1*0701 
A llele 
TNF-238.2 h omozygous 
TN F-238.2 heterozygous ;md homozygous 
HLA-Cw6 
HLA-1357 
H LA-D ltB I *070 '1 
Psod ::asis 
R .. R 
65 
8.2 
5.3 
14 
1.3 
11No TNF-238 .2 homozygous individuals with PsA were observed. 
PsA 
R.R 
6.3 
2.0 
4.6 
0.65 
in 1-:ILA class I and class II fi·equ encies . T he high Rl~ in TNF-238.2 
ho mozygotes is parall eled by a stro ng RR fo r HLA-B57. 
DISCUSS ION 
M ore than 20 years after th e initial descri ption of an HLA association 
of psori asis (Russell et nl, 1972; White el a/, 1972) there is sti ll li ttl e 
evidence fo r a direct involvement of HLA-Cw6 as an antigen-
presenting molecule in th e disease pa thogenesis. R ecent in vestiga tions 
have shown that the extended haplotype Cw6-B57-C4A6-D R 7 rather 
th an only Cw6 is disease associated (Schmi tt-Egenolf l'l nl, 1993). 
T herefore other M J-l C-encoded genes may be attrac ti ve ca nd idates to 
exp lain the observed H LA association . O ur study shows tha t the TN F-
238 .2 promoter polymorphism has a stronger associatio n with juvenil e 
onset psori asis and PsA than Cw6. It is impossible to dissect the strong 
associati o n of B57 and TNF-238.2 in th e psoriasis group any furth er 
because of the strong li nkage disequilibrium between th ese two alleles. 
T he high RR for psori asis confe rred by homozygosity fo r TNF-238 .2 
and th e increased fi·equency ofTNF-238.2 in the PsA gro up argue for 
th e importan ce of this polym orphism . In PsA subj ec ts, TNF-238 .2 
shows the stro ngest disease predispositio n (R.R .. = 6.3) altho ugh there 
is a slightly diffe rent HLA class I associati o n compared with the psori asis 
gro up (Cw6: 33.3% vs 56.7%, respectively; B 57: 15.9 liS 36.7%; RR.s 
in Table ill). 
In current models of psori asis TN F-a is tho ught to be an 
important medi ator in the ini ti ati on phase of cutaneous inflammatio n 
in pso ri asis (Barker et al, 199 1 ). Ph ys ical and chemical stimu li 
(Ba rke r et nl, 1991) have been shown to indu ce TNF-a productio n 
by keratinocytes. TNF~a release induces the ac tivation of dermal 
endo th elial ce lls with the ex press ion of adhesion mo lecules like 
ICAM- 1 (Barker et a/, 1990), ELAM - 1 (Bevih cqua et nl, 1987), 
and VCAM-1 (Osborn et al, 1989) and the recruitm ent o f 
infl ammatory cells like T-lymphocytes (Valdim arsson ct nl, 1995) 
and neutropb.ils. ln the subsequent antigen-dependent amplification 
phase of inflammation, TN F-a and I FN-y are released by th e 
recru ited inflammatory cells. Th ese cytokin es are important stimulators 
fo r the MHC class 11 expression of kerati nocy te (Barker er nl, 1991). 
ln additi on they stimulate the produ ctio n of chern otactic substances 
like IL-8 (B arker et a/, 1990) with the co nseq uence o f further 
amplifica tio n of the inflamm atory process . T N F-a and IFN-y have 
also been shown to stimulate TG F-a producti on by keratinocytes 
(Nicko loff et a/, 1991 ), the cyto kin e th ought to be responsible fo r 
the hyperproli fe ration of the ke ratin ocytes . 
T he T NF-238.2 polymorphism lies in a putative regulatory box 
(Y-box) of the T NF-a promo ter region w hich binds to regulatory 
DNA-binding proteins li ke NF- Y (D'AJfo nso and Ri chiardi , 1994). 
N ucleotide position -238 is stro ngly conserved amo ng different 
animal species, raising the possibility that it is fun cti onally important 
(Shakov et a/, 1990). T he Y-box is beli eved to contr ibu te to optimal 
promoter activity (D'Aifonso and Ri chiardi , l994) . A single base 
pair substitutio n in the Y-box o f th e H LA-DQA 1 pro moter ca uses 
significa ntly decreased transcription of th e gene (H aas ct a/, 1995; 
Morzycka-Wroblewska ct a/, 1997). M onocytes of T N F-238 A/G 
heterozygous subjects show increased T NF-a productio n after LPS 
treatment or allogenic stimulati on (Pocio t et a/, 1995), altho ugh the 
differences in TNF-a produ ction did not reach stati stical significa nce 
beca use of the low number of persons tested. 
T H E JOU I't.NA L F INVESTIGAT IVE DERMATOLOGY 
ln our study a much stronger l~ to develop psoriasis or PsA 
is associated w ith the TNF-238.2 promoter mutatio n than with 
HLA-Cw6. As lo ng as there is no defini te proof of a direct 
fun ctional involvem ent o f Cw6 in psoriasis o th er genes should be 
considered as possible candidates . Several genes might be in volved 
in the disease pathogenesis as is suggested by the strong haplotype 
conserva tio n observed in o ur study, particularly in the pso ri asis 
group . A cytokine imbablJ ce ca used by altered TNF- a secretio n in 
pati ents ca rryin g the T NF-238 .2 mutati on could be an important 
facto r in the disease path ogenesis. Furth er studi es are requi red to 
assess the fun cti o nal consequences o f this polymorphism in afFected 
individuals. 
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